UNSPSC 51182702: Glimepiride/rosiglitazone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HS502. This VA Drug Class (HS502) classifies this compound as belonging to the group ORAL HYPOGLYCEMIC AGENTS, ORAL.

UNSPSC 51182702 Glimepiride/rosiglitazone is a Commodity code that does not align with recent state and local procurement activity under this designation. The single recent opportunity tagged to this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and drug deactivation systems for public health use, which falls outside the pharmaceutical diabetes-management scope the code nominally describes. The mismatch suggests either a classification error in the county's procurement system or a system-wide tagging anomaly; the work being bought does not match the code's stated product line.

No recent state and local contract opportunities support procurement of glimepiride/rosiglitazone or closely related pharmaceutical products under this code. Absent additional evidence of active solicitation under the correct commodity scope, this code shows little current visibility in the state and local market. Business development professionals should verify whether their pharmaceutical product offerings are being sourced through alternative UNSPSC codes, state health department cooperative purchasing frameworks, or direct relationship channels rather than through general commodity code solicitations.